DE69528288T2 - Indolderivate zur behandlung von migräne - Google Patents

Indolderivate zur behandlung von migräne

Info

Publication number
DE69528288T2
DE69528288T2 DE69528288T DE69528288T DE69528288T2 DE 69528288 T2 DE69528288 T2 DE 69528288T2 DE 69528288 T DE69528288 T DE 69528288T DE 69528288 T DE69528288 T DE 69528288T DE 69528288 T2 DE69528288 T2 DE 69528288T2
Authority
DE
Germany
Prior art keywords
treating migraine
indolder derivatives
indolder
derivatives
migraine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69528288T
Other languages
English (en)
Other versions
DE69528288D1 (de
Inventor
James Wythes
Paul Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Pfizer Research and Development Co NV SA
Original Assignee
Pfizer Ltd
Pfizer Research and Development Co NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420529A external-priority patent/GB9420529D0/en
Priority claimed from GBGB9511401.3A external-priority patent/GB9511401D0/en
Application filed by Pfizer Ltd, Pfizer Research and Development Co NV SA filed Critical Pfizer Ltd
Publication of DE69528288D1 publication Critical patent/DE69528288D1/de
Application granted granted Critical
Publication of DE69528288T2 publication Critical patent/DE69528288T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69528288T 1994-10-12 1995-09-29 Indolderivate zur behandlung von migräne Expired - Fee Related DE69528288T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9420529A GB9420529D0 (en) 1994-10-12 1994-10-12 Indoles
GBGB9511401.3A GB9511401D0 (en) 1995-06-06 1995-06-06 Indoles
PCT/EP1995/003885 WO1996011923A1 (en) 1994-10-12 1995-09-29 Indole derivative for the treatment of migraine

Publications (2)

Publication Number Publication Date
DE69528288D1 DE69528288D1 (de) 2002-10-24
DE69528288T2 true DE69528288T2 (de) 2003-01-16

Family

ID=26305778

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528288T Expired - Fee Related DE69528288T2 (de) 1994-10-12 1995-09-29 Indolderivate zur behandlung von migräne

Country Status (9)

Country Link
EP (1) EP0804433B1 (de)
AT (1) ATE224388T1 (de)
CA (1) CA2213241C (de)
DE (1) DE69528288T2 (de)
DK (1) DK0804433T3 (de)
ES (1) ES2181791T3 (de)
FI (1) FI114155B (de)
PT (1) PT804433E (de)
WO (1) WO1996011923A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424471D0 (en) * 1994-12-03 1995-01-18 Pfizer Ltd Treatment of emesis
AU3170099A (en) * 1998-04-16 1999-11-08 Yamanouchi Pharmaceutical Co., Ltd. Remedies for obesity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2095360C1 (ru) * 1990-10-15 1997-11-10 Пфайзер Инк. Производные индола, их оптические изомеры и фармацевтически приемлемые соли
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.

Also Published As

Publication number Publication date
DE69528288D1 (de) 2002-10-24
CA2213241A1 (en) 1996-04-25
EP0804433B1 (de) 2002-09-18
EP0804433A1 (de) 1997-11-05
PT804433E (pt) 2002-12-31
WO1996011923A1 (en) 1996-04-25
CA2213241C (en) 2001-07-10
DK0804433T3 (da) 2002-10-14
ATE224388T1 (de) 2002-10-15
FI114155B (fi) 2004-08-31
ES2181791T3 (es) 2003-03-01
FI973382A (fi) 1997-08-18
FI973382A0 (fi) 1997-08-18

Similar Documents

Publication Publication Date Title
DE69400824D1 (de) Indol-derivate als 5-ht1-ähnliche antagonisten zur behandlung von migräne
BR9206810A (pt) Derivados de indol
FI970148A0 (fi) Heterosyklisten yhdisteiden käyttö dopamiini-D3-ligandeina
TR200000059T2 (tr) Piridin türevleri
ATE396722T1 (de) Kleine moleküle zur behandlung von endzündlichen erkrankungen
DK0772604T3 (da) Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander
DK0629199T3 (da) Indolderivater som 5-HT1 agonister
TR199500956A2 (tr) Benzimidazol türevleri.
ATE236169T1 (de) Heterocyclisch kondensierte morphinoid-derivate
DE69528288D1 (de) Indolderivate zur behandlung von migräne
DE60009315D1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
YU22802A (sh) Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina
YU29496A (sh) So pirolidinil metil indola
SE9404438D0 (sv) New process
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
MX9704299A (es) Derivados de bencimidazol.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee